ArticleLifetime data analysis2025

Assessing delayed treatment benefits of immunotherapy using long-term average hazard: a novel test/estimation approach.

Miki Horiguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.